US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

OM Asset Management plc

25.26

+0.0000

Volume:- -

Turnover:- -

Market Cap:2.16B

PE:10.31

High:25.26

Open:25.26

Low:25.26

Close:25.26

Loading ...

Overview Company News Filings

TD Bank Group provides insurance catastrophe information

BSA Limited Reports Strong Q3 Performance Amid Contract Challenges

BSA Limited Announces Quotation of New Securities on ASX

BSA Expects EBITDA for Fiscal 2025 Third Quarter of Around AU$7 Million

MT Newswires Live

BSA Sees AU$6.5 Million Restructuring Costs, Shares Plunge 26%

MT Newswires Live

Coinbase Report: 83% of Institutions Plan to Increase Cryptocurrency Investments by 2025

Did Binance.US Accidentally Swap Equity for Pardon? CZ Clarifies No Such Thing

Zevra Reports Full Year 2024 and Fourth Quarter Financial Results

Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting

Atos launches a reverse stock split

HyBryte™ Treatment Studies Presented at Two Medical Conferences in March

Press Release: TD Bank Group Management Proxy Circular Now Available; New Director Nominee Announced

TD Bank Group Reports First Quarter 2025 Results

U.S. FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis

ADOCIA Announces the Successful Completion of a €9.7 Million Private Placement, Extending its Cash Runway to Q2 2026

The Toronto-Dominion Bank Receives Regulatory Approval for Normal Course Issuer Bid

BSA First Half 2025 Earnings: EPS: AU$0.11 (vs AU$0.11 in 1H 2024)

Simply Wall St.

Arcutis Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE® (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with Mild to Moderate Atopic Dermatitis in Pediatric Dermatology

BSA Limited Releases Interim Results and Announces Investor Briefing

BSA Limited Announces New Securities Quotation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BSA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BSA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSA\",,,,,undefined,":{"symbol":"BSA","market":"US","secType":"STK","nameCN":"OM Asset Management plc","latestPrice":25.26,"timestamp":1688155200000,"preClose":25.26,"halted":0,"volume":0,"delay":0,"floatShares":64989934,"shares":85689773,"eps":2.449999,"marketStatus":"Pre-Mkt","change":0,"latestTime":"05-09 08:52:41 EDT","open":25.26,"high":25.26,"low":25.26,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.449999,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746797400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.26,"dividendRate":0.015835,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSA\",,,,,undefined,":{"symbol":"BSA","floatShares":64989934,"roa":"12.27%","roe":"128.17%","lyrEps":2.453801,"shares":85689773,"dividePrice":0.4,"high":25.26,"amplitude":0,"preClose":25.26,"low":25.26,"week52Low":24.86,"pbRate":"33.61","week52High":26.23,"institutionHeld":0,"latestPrice":25.26,"eps":2.449999,"divideRate":0.015835,"volume":0,"delay":0,"ttmEps":2.449999,"open":25.26,"prevYearClose":25.27},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BSA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533004565","title":"TD Bank Group provides insurance catastrophe information","url":"https://stock-news.laohu8.com/highlight/detail?id=2533004565","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533004565?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:00","pubTimestamp":1746478800,"startTime":"0","endTime":"0","summary":"TORONTO, May 5, 2025 /CNW/ - TD Bank Group    announced today that it expects catastrophe claims of approximately $50 million after reinsurance and before tax to be reflected in the Bank's Wealth Management & Insurance segment's second-quarter results.Catastrophe claims are insurance claims that relate to any single event that occurred in the relevant fiscal quarter, for which the aggregate insurance claims are equal to or greater than an internal threshold of $5 million before reinsurance. The Bank's internal threshold may change from time to time. The total amount of catastrophe claims presented reflects the estimated pre-tax cost of these claims net of recoveries from related reinsurance coverage and, when applicable, includes the cost of reinsurance reinstatement premiums. The total amount of catastrophe claims is included in Insurance service expenses and amounts related to reinsurance coverage are included in Other income  on the Bank's Consolidated Statement of Income.TD will re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/td-bank-group-provides-insurance-210000491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TD","BSA","BK4566","BK4207","BK4585"],"gpt_icon":0},{"id":"2531543291","title":"BSA Limited Reports Strong Q3 Performance Amid Contract Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2531543291","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531543291?lang=en_us&edition=fundamental","pubTime":"2025-04-29 07:57","pubTimestamp":1745884653,"startTime":"0","endTime":"0","summary":"BSA Limited ( ($AU:BSA) ) has provided an update. BSA Limited reported a strong financial performance for Q3 FY2025, with a revenue increase of 12....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bsa-limited-reports-strong-q3-performance-amid-contract-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bsa-limited-reports-strong-q3-performance-amid-contract-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSA"],"gpt_icon":0},{"id":"2525881496","title":"BSA Limited Announces Quotation of New Securities on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2525881496","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525881496?lang=en_us&edition=fundamental","pubTime":"2025-04-08 10:47","pubTimestamp":1744080429,"startTime":"0","endTime":"0","summary":"BSA Limited ( ($AU:BSA) ) just unveiled an announcement. BSA Limited has announced the application for quotation of 187 ordinary fully paid securit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bsa-limited-announces-quotation-of-new-securities-on-asx-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bsa-limited-announces-quotation-of-new-securities-on-asx-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSA"],"gpt_icon":0},{"id":"2524269220","title":"BSA Expects EBITDA for Fiscal 2025 Third Quarter of Around AU$7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2524269220","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524269220?lang=en_us&edition=fundamental","pubTime":"2025-04-04 14:29","pubTimestamp":1743748144,"startTime":"0","endTime":"0","summary":"BSA  said it expects to report earnings before interest, taxes, depreciation, and amortization for the third fiscal quarter of 2025 will be around AU$7 million, before restructuring costs, according to a Friday Australian bourse filing.The firm reported changes to expected volumes for its existing smart metering contracts with Intellihub and Bluecurrent.The contracts contributed around AU$15 million in annual revenues however carry no volume guarantees. Intellihub volumes have been materially reduced such that the firm does not expect any revenue after April. Bluecurrent informed it that it is unlikely to enter into a new agreement in fiscal year 2026, however, impacts on volume are yet to be determined.The firm took steps to mitigate operational and financial impacts, including reallocation of resources and ongoing cost management initiatives.Its shares tumbled 22% on market close on Friday, reaching an all-time low point.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7055","BSA","BK7064","BSA.AU"],"gpt_icon":0},{"id":"2520174878","title":"BSA Sees AU$6.5 Million Restructuring Costs, Shares Plunge 26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2520174878","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520174878?lang=en_us&edition=fundamental","pubTime":"2025-03-20 13:34","pubTimestamp":1742448867,"startTime":"0","endTime":"0","summary":"BSA's   unified field operations contract with NBN Co expires on Sept. 30 and it expects work orders to progressively decline from around May with new orders stopping from about mid-July, the company said in a Thursday Australian bourse filing.After being unsuccessful at securing field module contract with NBN, the company said it expects restructuring costs of about AU$6.5 million in the current financial year with a cash flow impact of about AU$10 million including employee entitlements.The company's shares plunged 26% in recent Thursday trade, reaching a record low.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7055","BK7064","BSA","BSA.AU"],"gpt_icon":0},{"id":"2520910643","title":"Coinbase Report: 83% of Institutions Plan to Increase Cryptocurrency Investments by 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520910643","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520910643?lang=en_us&edition=fundamental","pubTime":"2025-03-19 14:04","pubTimestamp":1742364240,"startTime":"0","endTime":"0","summary":"Original Article Title: \"Coinbase Survey: 83% of Institutions Plan to Increase Cryptocurrency Investments by 2025\"Original Article Author: Arthur Wang, BlockTempoAccording to a report released yesterd","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info/en/news/57361","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_highlight","symbols":["BK4551","LU1861558580.USD","BK4112","BK4535","BK4585","BK4595","LU1861559042.SGD","COIN","BK4600","BK4516","BK4554","BSA","BK4596","BK4539","BK4588"],"gpt_icon":1},{"id":"2519481223","title":"Did Binance.US Accidentally Swap Equity for Pardon? CZ Clarifies No Such Thing","url":"https://stock-news.laohu8.com/highlight/detail?id=2519481223","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519481223?lang=en_us&edition=fundamental","pubTime":"2025-03-14 12:00","pubTimestamp":1741924800,"startTime":"0","endTime":"0","summary":"Original Title: \"Binance US Equity Acquisition Rumor?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info/en/news/57292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_highlight","symbols":["TON.USD.CC","APT.USD.HKCC","APT.USD.CC","BK4588","BSA","TON.USD.HKCC","EQR","BK4215","BK4585"],"gpt_icon":0},{"id":"2518710297","title":"Zevra Reports Full Year 2024 and Fourth Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2518710297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518710297?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:05","pubTimestamp":1741723500,"startTime":"0","endTime":"0","summary":"FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million duringfourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million  Company to host confer","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/11/3040981/16626/en/Zevra-Reports-Full-Year-2024-and-Fourth-Quarter-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4510","BK4124","CPS","AS","BK4563","BSA","IH","BK4085","BK4202"],"gpt_icon":0},{"id":"2517441685","title":"Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2517441685","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517441685?lang=en_us&edition=fundamental","pubTime":"2025-03-08 22:01","pubTimestamp":1741442460,"startTime":"0","endTime":"0","summary":"- Full data from the Phase 3 TRuE-PN1 study, presented today in a late-breaking oral presentation, showed the study met all primary and key secondary endpoints. - Topline data from a separate Phase 3 study, TRuE-PN2, showed that while the primary endpoint did not reach statistical significance, the primary and all key secondary endpoints were in favor of ruxolitinib cream 1.5% versus vehicle. WILMINGTON, Del., March 08, 2025----Incyte  today announced results from its pivotal Phase 3 TRuE-PN clinical trial program –TRuE-PN1 and TRuE-PN2 studies – evaluating the safety and efficacy of twice-daily ruxolitinib cream 1.5% , a topical JAK1/2 inhibitor, in adult patients  with prurigo nodularis . The positive TRuE-PN1 data were presented as a late-breaking oral presentation  today at the 2025 American Academy of Dermatology  Annual Meeting, being held March 7–11, 2025, in Orlando.Additionally, topline data from the Phase 3 TRuE-PN2 clinical trial demonstrated a strong positive trend across a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incyte-announces-results-phase-3-140100487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PN","BK4139","BSA","AFG","BK4107","BK4117","BK4585","BK4550","BK4588","INCY","BK4532"],"gpt_icon":0},{"id":"2517120935","title":"Atos launches a reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2517120935","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517120935?lang=en_us&edition=fundamental","pubTime":"2025-03-07 14:30","pubTimestamp":1741329000,"startTime":"0","endTime":"0","summary":"Paris, France - March 7, 2025. – Atos SE  announces the implementation of a reverse stock split of the shares comprising its share capital, through the exchange of 10,000 old shares of 0.0001 par value for 1 new share of 1.00 par value.Given the number of Atos shares issued during the capital increases carried out as part of the Company’s accelerated safeguard plan and the low share value, the reverse stock split aims to restore a normal number of shares, reduce share price volatility and support a new stock market dynamic.The reverse stock split is a purely technical exchange transaction with no direct impact on the total value of the Company’s shares held by each shareholder.For example, for a shareholder holding 30,000 shares before the operation:. Frequently Asked Questions  relating to the reverse stock split are available on the Company’s website in the “Investors” section.Main terms and conditions of the reverse stock split. Effective date of the reverse stock split: April 24, 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/atos-launches-reverse-stock-split-063000162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AEXAY","BK4134","BSA","AEXAF"],"gpt_icon":0},{"id":"2517086154","title":"HyBryte™ Treatment Studies Presented at Two Medical Conferences in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2517086154","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517086154?lang=en_us&edition=fundamental","pubTime":"2025-03-06 20:30","pubTimestamp":1741264200,"startTime":"0","endTime":"0","summary":"Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy. Conference: USCLC Workshop \"Cutaneous Lymphomas in Special Populations\" March 6, Orlando, Florida. The official conference program can be found here.Presentation Title: Topical hypericin ointment photodynamic therapy for early stage mycosis fungoides/CTCL – a Phase 2 real world investigator-initiated study presented by Dr. Ellen Kim, Director, Penn Cutaneous Lymphoma Program, Vice Chair of Clinical Operations, Dermatology Department, and Professor of Dermatology at the Hospital of the University of Pennsylvania.presented by Dr. Neal Bhatia, Director of Clinical Dermatology at Therapeutics Clinical Research and chief medical editor at Practical Dermatology. The official conference program can be found here.These presentations incorporate the Company's findings in recentsupportive studies which have demonstrated the utility of longer treatment times, t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/hybryte-treatment-studies-presented-two-123000102.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hybryte-treatment-studies-presented-two-123000102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BSA","IDR","SNGX","BK4168"],"gpt_icon":0},{"id":"2517981374","title":"Press Release: TD Bank Group Management Proxy Circular Now Available; New Director Nominee Announced","url":"https://stock-news.laohu8.com/highlight/detail?id=2517981374","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517981374?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:30","pubTimestamp":1741123800,"startTime":"0","endTime":"0","summary":"The Bank reminds shareholders that they can, and are encouraged to, vote their shares in advance of the meeting using the various methods available, including online or telephone voting. Instructions are included in the Circular, which shareholders are encouraged to read carefully.\"We encourage shareholders to read the Circular to learn more about the significant actions TD has taken to deliver accountability and strengthen oversight, remediate our U.S. AML program and bring experienced new leaders to the Board,\" said Alan MacGibbon, Chair of the Board, TD Bank Group. \"Under the leadership of our new CEO, Raymond Chun, TD is moving decisively to drive change, build for the future, earn the ongoing confidence of our shareholders and deliver long-term value.\". As highlighted in the Circular, Ana Arsov will stand for election at the meeting as a new director nominee. Ms. Arsov joins the other highly qualified leaders with experience in global banking, governance, risk management, and regu","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSA","BK4207","BK4566","BK4585","TD"],"gpt_icon":0},{"id":"2514808756","title":"TD Bank Group Reports First Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514808756","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514808756?lang=en_us&edition=fundamental","pubTime":"2025-02-27 19:30","pubTimestamp":1740655800,"startTime":"0","endTime":"0","summary":"Earnings News ReleaseThree months ended January 31, 2025. Reported results conform with generally accepted accounting principles , in accordance with IFRS. Adjusted results are non-GAAP financial measures. For additional information about the Bank's use of non-GAAP financial measures, refer to \"Significant and Subsequent Events\" and \"Non-GAAP and Other Financial Measures\" in the \"How We Performed\" section of this document.FIRST QUARTER FINANCIAL HIGHLIGHTS, compared with the first quarter last year:. Reported diluted earnings per share were $1.55, compared with $1.55.Adjusted diluted earnings per share were $2.02, compared with $2.00.Reported net income was $2,793 million, compared with $2,824 million.Adjusted net income was $3,623 million, compared with $3,637 million.FIRST QUARTER ADJUSTMENTS  The first quarter reported earnings figures included the following items of note:. Acquisition and integration charges related to the Cowen acquisition of $52 million , compared with $117 milli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/td-bank-group-reports-first-113000908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4566","BK4229","FHN","FCRM","ROE","BK4589","BK4195","BSA","BK4020","BK4207","OCC","BK4211","TD","BK4585"],"gpt_icon":0},{"id":"2514283726","title":"U.S. FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2514283726","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514283726?lang=en_us&edition=fundamental","pubTime":"2025-02-26 21:00","pubTimestamp":1740574800,"startTime":"0","endTime":"0","summary":"U.S. Food and Drug Administration (FDA) has set a Prescription Drug User Fee Act (PDUFA) target action date of October 13, 2025Application supported by positive efficacy and safety data from pivotal P","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032866/0/en/U-S-FDA-Accepts-Supplemental-New-Drug-Application-for-Arcutis-ZORYVE-roflumilast-Cream-0-05-for-the-Treatment-of-Children-Aged-2-to-5-with-Mild-to-Moderate-Atopic-Dermatitis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSA"],"gpt_icon":0},{"id":"2514400795","title":"ADOCIA Announces the Successful Completion of a €9.7 Million Private Placement, Extending its Cash Runway to Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2514400795","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514400795?lang=en_us&edition=fundamental","pubTime":"2025-02-26 15:42","pubTimestamp":1740555720,"startTime":"0","endTime":"0","summary":"Capital increase of a total amount of 9.7 million in gross proceeds by issuing a total number of 2,125,000 new shares, each with one share warrant attached, at 4.58 per share. Gross Proceeds include 0.5 million from Gerard Soula, chairman of the Board and co-founder of the Company, 0.9 million from Vester Finance, an historical investor, 7 million from Armistice Capital and 1.3 million from a limited number of investors. Settlement-delivery of the new shares and share warrants expected on February 28, 2025. \"The success of this private placement significantly strengthens our cash position in a favorable context for Adocia. The company holds high-potential projects that are ready for licensing, such as M1Pram and BioChaperone CagriSema. The participation of Gérard Soula, Chairman and Co-Founder, along with historical shareholders and new investors, demonstrates their confidence in Adocia’s short-term potential,\" said Olivier Soula, Chief Executive Officer of Adocia.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adocia-announces-successful-completion-9-074200948.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADOCY","EU","BSA","BK4139","BK4156"],"gpt_icon":0},{"id":"2514012847","title":"The Toronto-Dominion Bank Receives Regulatory Approval for Normal Course Issuer Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2514012847","media":"CNW Group","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514012847?lang=en_us&edition=fundamental","pubTime":"2025-02-25 06:00","pubTimestamp":1740434400,"startTime":"0","endTime":"0","summary":"TORONTO, Feb. 24, 2025 /CNW/ - The Toronto-Dominion Bank    announced today that the Toronto Stock Exchange  and the Office of the Superintendent of Financial Institutions Canada have approved TD's previously announced normal course issuer bid  to purchase for cancellation up to 100 million of its common shares. The Bid will commence on March 3, 2025 and end on February 28, 2026, or such earlier date as TD may determine.TD will make purchases under the Bid through the facilities of the TSX as well as through other designated exchanges and alternative trading systems in Canada. Additionally, purchases may be made through the facilities of the New York Stock Exchange or other designated exchanges and published markets in the U.S. The purchases will be made in accordance with applicable securities laws and regulatory requirements. The price paid for such purchased shares will be the prevailing market price of such common shares at the time of acquisition or such other price as may be perm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/toronto-dominion-bank-receives-regulatory-220000185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BSA","TD","BK4566","BK4207","BK4585"],"gpt_icon":0},{"id":"2514370605","title":"BSA First Half 2025 Earnings: EPS: AU$0.11 (vs AU$0.11 in 1H 2024)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514370605","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514370605?lang=en_us&edition=fundamental","pubTime":"2025-02-25 04:44","pubTimestamp":1740429875,"startTime":"0","endTime":"0","summary":"Profit margin: 5.3% . The decrease in margin was driven by higher expenses.ASX:BSA Earnings and Revenue Growth February 24th 2025. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 5.8% p.a. on average during the next 2 years, compared to a 6.5% growth forecast for the Construction industry in Australia.The company's shares are down 86% from a week ago.Before we wrap up, we've discovered 3 warning signs for BSA that you should be aware of.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bsa-first-half-2025-earnings-204435295.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BSA.AU","BSA"],"gpt_icon":0},{"id":"2513726666","title":"Arcutis Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE® (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with Mild to Moderate Atopic Dermatitis in Pediatric Dermatology","url":"https://stock-news.laohu8.com/highlight/detail?id=2513726666","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513726666?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:00","pubTimestamp":1740402000,"startTime":"0","endTime":"0","summary":"ZORYVE (roflumilast) cream 0.05% improved atopic dermatitis (AD) across all primary and secondary efficacy endpoints, with significant improvement as early as Week 1 on multiple efficacy endpoints.39.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/24/3031084/0/en/Arcutis-Announces-Publication-of-Positive-Data-from-INTEGUMENT-PED-Trial-Evaluating-ZORYVE-roflumilast-Cream-0-05-in-Children-2-to-5-Years-Old-with-Mild-to-Moderate-Atopic-Dermatit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PED","BK4213","BSA","BK4563"],"gpt_icon":0},{"id":"2512747453","title":"BSA Limited Releases Interim Results and Announces Investor Briefing","url":"https://stock-news.laohu8.com/highlight/detail?id=2512747453","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512747453?lang=en_us&edition=fundamental","pubTime":"2025-02-20 06:51","pubTimestamp":1740005512,"startTime":"0","endTime":"0","summary":"BSA Limited ( ($AU:BSA) ) just unveiled an announcement. BSA Limited released its interim results for the half-year ending December 31, 2024, and a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bsa-limited-releases-interim-results-and-announces-investor-briefing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bsa-limited-releases-interim-results-and-announces-investor-briefing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSA"],"gpt_icon":0},{"id":"2512458003","title":"BSA Limited Announces New Securities Quotation","url":"https://stock-news.laohu8.com/highlight/detail?id=2512458003","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512458003?lang=en_us&edition=fundamental","pubTime":"2025-02-20 06:38","pubTimestamp":1740004686,"startTime":"0","endTime":"0","summary":"BSA Limited ( ($AU:BSA) ) has issued an update. BSA Limited has announced a new issuance of 96,000 fully paid ordinary securities, to be quoted on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bsa-limited-announces-new-securities-quotation-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bsa-limited-announces-new-securities-quotation-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BSA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BSA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-01-18","symbol":"BSA","amount":0.29,"defaultRemindTime":1642516200000,"name":"OM Asset Management plc","recordDate":"2022-01-18","payableDate":"2022-01-18","currency":"USD","type":"dividend","dateTimestamp":1642482000000},{"market":"US","date":"2022-01-18","symbol":"BSA","reason":null,"defaultRemindTime":1642516200000,"announcedDate":"2021-12-17","type":"delisting","dateTimestamp":1642482000000},{"market":"US","date":"2021-10-08","symbol":"BSA","amount":0.3203125,"defaultRemindTime":1633699800000,"name":"OM Asset Management plc","recordDate":"2021-10-27","payableDate":"2021-10-12","currency":"USD","type":"dividend","dateTimestamp":1633665600000},{"market":"US","date":"2021-07-09","symbol":"BSA","amount":0.3203125,"defaultRemindTime":1625837400000,"name":"OM Asset Management plc","recordDate":"2021-07-27","payableDate":"2021-07-12","currency":"USD","type":"dividend","dateTimestamp":1625803200000},{"market":"US","date":"2021-04-09","symbol":"BSA","amount":0.3203125,"defaultRemindTime":1617975000000,"name":"OM Asset Management plc","recordDate":"2021-04-27","payableDate":"2021-04-12","currency":"USD","type":"dividend","dateTimestamp":1617940800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BSA\",market:\"US\",,,undefined,":[{"executeDate":"2018-04-11","recordDate":"2018-04-12","paymentDate":"2018-04-27","value":0.3203125,"currency":"USD"},{"executeDate":"2018-07-11","recordDate":"2018-07-12","paymentDate":"2018-07-27","value":0.3203125,"currency":"USD"},{"executeDate":"2018-10-11","recordDate":"2018-10-12","paymentDate":"2018-10-27","value":0.3203125,"currency":"USD"},{"executeDate":"2019-01-10","recordDate":"2019-01-12","paymentDate":"2019-01-27","value":0.3203125,"currency":"USD"},{"executeDate":"2019-04-11","recordDate":"2019-04-12","paymentDate":"2019-04-27","value":0.3203125,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BSA\",market:\"US\",delay:false,,,undefined,":{}}}